1. Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody
   Winn Aung et al, 2018, World Journal of Gastroenterology CrossRef
2. Influence of the dissociation rate constant on the intra-tumor distribution of antibody-drug conjugate against tissue factor
   Ryo Tsumura et al, 2018, Journal of Controlled Release CrossRef
3. Nanobody Conjugates for Targeted Cancer Therapy and Imaging
   Wei Kang et al, 2021, Technology in Cancer Research & Treatment CrossRef
4. Inhibition of the Classical Pathway of Complement Activation Impairs Bacterial Clearance during Enterococcus faecalis Infection
   Eman M. Rabie Shehab El-Din et al, 2021, Infection and Immunity CrossRef
5. Molecular imaging using an anti-human tissue factor monoclonal antibody in an orthotopic glioma xenograft model
   Hiroki Takashima et al, 2017, Scientific Reports CrossRef
6. Pharmacokinetics of protein and peptide conjugates
   Brandon Bumbaca et al, 2019, Drug Metabolism and Pharmacokinetics CrossRef
7. Preclinical Studies of ADC Therapy for Solid Tumors
   Yoshikatsu Koga et al, 2019, Cancer Drug Delivery Systems Based on the Tumor Microenvironment CrossRef
8. Preclinical studies of immunomicelles incorporating anticancer drugs
   Hiroki Takashima et al, 2019, Drug Delivery System CrossRef
9. Evaluation of the antitumor mechanism of antibody‐drug conjugates against tissue factor in stroma‐rich allograft models
   Ryo Tsumura et al, 2019, Cancer Science CrossRef
10. Modification of nitric oxide donors onto a monoclonal antibody boosts accumulation in solid tumors
    Takuma Yoshikawa et al, 2020, International Journal of Pharmaceutics CrossRef
11. Reinforcement of antitumor effect of micelles containing anticancer drugs by binding of an anti-tissue factor antibody without direct cytocidal effects
    Hiroki Takashima et al, 2020, Journal of Controlled Release CrossRef
12. Covalently Engineered Nanobody Chimeras for Targeted Membrane Protein Degradation
    Heng Zhang et al, 2021, Journal of the American Chemical Society CrossRef
13. Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancer
    Seyed Esmaeil Ahmadi et al, 2023, Biomarker Research CrossRef
14. Radioimmunotherapy with an 211At‐labeled anti–tissue factor antibody protected by sodium ascorbate
    Hiroki Takashima et al, 2021, Cancer Science CrossRef
15. The natural sulfoglycolipid derivative SQAP improves the therapeutic efficacy of tissue factor-targeted radioimmunotherapy in the stroma-rich pancreatic cancer model BxPC-3
    Yoichi Takakusagi et al, 2022, Translational Oncology CrossRef
16. Functional Characteristics and Regulated Expression of Alternatively Spliced Tissue Factor: An Update
    Kateryna Matiash et al, 2021, Cancers CrossRef